Renin-Angiotensin-Aldosterone Inhibitors and COVID-19

被引：0
|
作者：
Benenson, Irina [1 ]
Waldron, Frederick [2 ]
机构：
[1] Rutgers State Univ, Sch Nursing, Newark, NJ 07102 USA
[2] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.nurpra.2020.05.007
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
[No abstract available]
引用
收藏
页码：545 / 546
页数：2
相关论文
共 50 条
  • [31] Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
    Vasiliki Tsampasian
    Natasha Corballis
    Vassilios S. Vassiliou
    Current Hypertension Reports, 2022, 24 : 425 - 433
  • [32] Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea
    Son, Minkook
    Seo, Jeongkuk
    Yang, Sung
    HYPERTENSION, 2020, 76 (03) : 742 - 749
  • [33] A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
    Usman, Muhammad Shariq
    Siddiqi, Tariq Jamal
    Khan, Muhammad Shahzeb
    Ahmed, Areeba
    Ali, Syed Saad
    Michos, Erin D.
    Hall, Michael E.
    Krasuski, Richard A.
    Greene, Stephen J.
    Butler, Javed
    Alkhouli, Mohamad
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 159 - 161
  • [34] Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
    Golpe, Rafael
    Perez-de-Llano, Luis A.
    Dacal, David
    Guerrero-Sande, Hector
    Pombo-Vide, Beatriz
    Ventura-Valcarcel, Pablo
    MEDICINA CLINICA, 2020, 155 (11): : 488 - 490
  • [35] Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy
    Tomasoni, Daniela
    Petrie, Mark C.
    Adamo, Marianna
    Metra, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (03) : 486 - 488
  • [36] Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
    Hassib, Mohab
    Hamilton, Steven
    Elkhouly, Ahmed
    Li, Yiting
    Kaplan, Adam C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [37] Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
    Kutz, Alexander
    Conen, Anna
    Gregoriano, Claudia
    Haubitz, Sebastian
    Koch, Daniel
    Domenig, Oliver
    Bernasconi, Luca
    Mueller, Beat
    Schuetz, Philipp
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 184 (04) : 543 - 552
  • [38] Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19
    Yasushi Matsuzawa
    Kazuo Kimura
    Hisao Ogawa
    Kouichi Tamura
    Hypertension Research, 2022, 45 : 1147 - 1153
  • [39] Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
    Katsiki, Niki
    Banach, Maciej
    Mikhailidis, Dimitri P.
    ARCHIVES OF MEDICAL SCIENCE, 2020, 16 (03) : 485 - 489
  • [40] Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension
    Mahanaimy, Moria
    Finkel, Uriah
    Barda, Noam
    Rottman, Eytan
    Balicer, Ran
    Senderey, Adi Berliner
    Feldman, Becca
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (05): : 310 - 316
12345